{"DataElement":{"publicId":"3186684","version":"2","preferredName":"Post Surgical Procedure Assessment Thyroid Gland Carcinoma Status","preferredDefinition":"Text term to describe a person's condition within three months after surgery and adjuvant therapy to treat a thyroid gland carcinoma.","longName":"3186651v1.0:3186657v1.1","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3186651","version":"1","preferredName":"Thyroid Gland Carcinoma Post Surgical Procedure Assessment","preferredDefinition":"A highly vascular endocrine gland consisting of two lobes, one on either side of the trachea, joined by a narrow isthmus; it produces the thyroid hormones which are concerned in regulating the metabolic rate of the body._A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004_Post; occuring after._A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery._Having determined the value, significance, or extent of.","longName":"3185657v1.0:3186649v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3185657","version":"1","preferredName":"Thyroid Gland Carcinoma","preferredDefinition":"A highly vascular endocrine gland consisting of two lobes, one on either side of the trachea, joined by a narrow isthmus; it produces the thyroid hormones which are concerned in regulating the metabolic rate of the body.:A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004","longName":"C12400:C2916","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland","conceptCode":"C12400","definition":"An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A9A5F9B-34BD-35BA-E040-BB89AD430E58","latestVersionIndicator":"Yes","beginDate":"2011-01-24","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-24","modifiedBy":"ONEDATA","dateModified":"2011-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3186649","version":"1","preferredName":"Post Surgical Procedure Assessment","preferredDefinition":"Post; occuring after.:A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.:Having determined the value, significance, or extent of.","longName":"C38008:C15329:C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Surgical Procedure","conceptCode":"C15329","definition":"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AADAEB7-4277-BED0-E040-BB89AD43239D","latestVersionIndicator":"Yes","beginDate":"2011-01-25","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-25","modifiedBy":"ONEDATA","dateModified":"2011-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AADAEB7-4288-BED0-E040-BB89AD43239D","latestVersionIndicator":"Yes","beginDate":"2011-01-25","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-25","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 1/2011","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3186657","version":"1.1","preferredName":"Thyroid Gland Carcinoma Status","preferredDefinition":"A highly vascular endocrine gland consisting of two lobes, one on either side of the trachea, joined by a narrow isthmus; it produces the thyroid hormones which are concerned in regulating the metabolic rate of the body._A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004_A condition or state at a particular time.","longName":"3186657v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Persistent distant metastases","valueDescription":"Distant Metastasis Persistent Disease","ValueMeaning":{"publicId":"3186658","version":"1","preferredName":"Distant Metastasis Persistent Disease","longName":"3186658","preferredDefinition":"Refers to cancer that has spread from the original (primary) tumor to distant organs or distant lymph nodes.: A disease that does not go to remission despite treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Distant Metastasis","conceptCode":"C18206","definition":"A biological process that involves the transfer and growth of cancer cells from the site of the primary tumor. Relocation of malignant cells during metastasis can be restricted to movement within a specific tissue/organ or may entail migration to a distal locus within the body. This phenotype is a characteristic of all malignant tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Persistent Disease","conceptCode":"C90169","definition":"A disease that does not go to remission despite treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AADC637-3F96-988C-E040-BB89AD430DC9","latestVersionIndicator":"Yes","beginDate":"2011-01-25","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2AE5999-3D2D-98A7-E040-BB89AD43040E","beginDate":"2011-01-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-07-29","modifiedBy":"ONEDATA","dateModified":"2013-07-29","deletedIndicator":"No"},{"value":"Persistent locoregional disease","valueDescription":"Local-Regional Persistent Disease","ValueMeaning":{"publicId":"3186681","version":"1","preferredName":"Local-Regional Persistent Disease","longName":"3186681","preferredDefinition":"Local-Regional; affecting only a restricted part or area of the body.: A disease that does not go to remission despite treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Local-Regional","conceptCode":"C25388","definition":"Of or belonging to both a local and regional area of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Persistent Disease","conceptCode":"C90169","definition":"A disease that does not go to remission despite treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AADC637-3FBC-988C-E040-BB89AD430DC9","latestVersionIndicator":"Yes","beginDate":"2011-01-25","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2AE5999-3D37-98A7-E040-BB89AD43040E","beginDate":"2011-01-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-07-29","modifiedBy":"ONEDATA","dateModified":"2013-07-29","deletedIndicator":"No"},{"value":"No imaging evidence of disease","valueDescription":"No Evidence of Disease Radiologic Finding","ValueMeaning":{"publicId":"3186682","version":"1","preferredName":"No Evidence of Disease Radiologic Finding","longName":"3186682","preferredDefinition":"Diagnostic tests fail to detect presence of disease.: Results that have been obtained through x-ray imaging.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No Evidence of Disease","conceptCode":"C40413","definition":"Diagnostic tests fail to detect presence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Radiologic Finding","conceptCode":"C35869","definition":"Imaging results obtained through a radiology procedure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AADC637-3FE2-988C-E040-BB89AD430DC9","latestVersionIndicator":"Yes","beginDate":"2011-01-25","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2AE5999-3D41-98A7-E040-BB89AD43040E","beginDate":"2011-01-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-07-29","modifiedBy":"ONEDATA","dateModified":"2013-07-29","deletedIndicator":"No"},{"value":"Not Available","valueDescription":"Negation Availability","ValueMeaning":{"publicId":"3186683","version":"1","preferredName":"Negation Availability","longName":"3186683","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Available; obtainable or accessible and ready for use or service.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Availability","conceptCode":"C25429","definition":"The quality of being obtainable or accessible and ready for use or service.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AADC637-4008-988C-E040-BB89AD430DC9","latestVersionIndicator":"Yes","beginDate":"2011-01-25","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2AE5999-3D4B-98A7-E040-BB89AD43040E","beginDate":"2011-01-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-07-29","modifiedBy":"ONEDATA","dateModified":"2013-07-29","deletedIndicator":"No"},{"value":"Biochemical Evidence of Disease","valueDescription":"Biochemical Evidence of Disease","ValueMeaning":{"publicId":"3166454","version":"1","preferredName":"Biochemical Evidence of Disease","longName":"3166454","preferredDefinition":"Of or relating to biochemistry; involving chemical processes in living organisms.: Knowledge on which to base belief.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biochemical","conceptCode":"C25434","definition":"Of or relating to biochemistry; involving chemical processes in living organisms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Evidence","conceptCode":"C43583","definition":"Knowledge on which to base belief.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9766E8FC-EFBE-9808-E040-BB89AD434090","latestVersionIndicator":"Yes","beginDate":"2010-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-12-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2AE5999-3D65-98A7-E040-BB89AD43040E","beginDate":"2013-07-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-07-29","modifiedBy":"ONEDATA","dateModified":"2013-07-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3186656","version":"1","preferredName":"Thyroid Gland Carcinoma Status","preferredDefinition":"A highly vascular endocrine gland consisting of two lobes, one on either side of the trachea, joined by a narrow isthmus; it produces the thyroid hormones which are concerned in regulating the metabolic rate of the body.:A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004:A condition or state at a particular time.","longName":"C12400:C2916:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland","conceptCode":"C12400","definition":"An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AADC637-3F6B-988C-E040-BB89AD430DC9","latestVersionIndicator":"Yes","beginDate":"2011-01-25","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-25","modifiedBy":"ONEDATA","dateModified":"2011-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2AE5999-3D17-98A7-E040-BB89AD43040E","latestVersionIndicator":"Yes","beginDate":"2011-01-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-07-29","modifiedBy":"COOPERM","dateModified":"2013-07-29","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 1/2011 sw Extended max length to add PV per request by Tara. mc 7/29/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787521","version":"1","longName":"THCA","context":"NCIP"}]}],"AlternateNames":[{"name":"post_surgical_procedure_assessment_thyroid_gland_carcinoma_status","type":"TCGA_XML_Name","context":"NCIP"}],"ReferenceDocuments":[{"name":"TCGA Comment","type":"COMMENT","description":"Check all that apply","url":null,"context":"NCIP"},{"name":"Clinical Status Within Three","type":"Preferred Question Text","description":"Clinical Status Within Three (3) Months of Surgery (surgery and adjuvant therapies)","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2AE5999-3D73-98A7-E040-BB89AD43040E","latestVersionIndicator":"Yes","beginDate":"2011-01-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-07-29","modifiedBy":"TSESU","dateModified":"2018-07-13","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 1/2011 Modified definition to replace system generated with human readable format per approval by Tara. mc 7/2/11 Versioned to extend VD max length to add PV. mc 7/29/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}